ClinConnect ClinConnect Logo
Search / Trial NCT05851534

Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · May 1, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Prehabilitation Pancreas Preoperative Optimisation

ClinConnect Summary

This clinical trial is looking at a special program designed to help patients prepare for surgery on the pancreas, particularly for those with pancreatic cancer. The study wants to find out if this prehabilitation program, which focuses on improving certain health factors before surgery, can help patients recover faster and reduce complications after their operation. The main questions are whether patients will get back to their normal activities sooner and whether there will be fewer overall complications from the surgery.

To participate in this trial, you need to be an adult aged 65 or older who is scheduled for surgery to treat pancreatic cancer, either as a first step or after some initial treatment. Unfortunately, younger patients (under 18) and those needing urgent surgery won't be able to join. If you decide to participate, you can expect to take part in a program that helps you improve your health before your surgery, which may lead to better outcomes in your recovery. The trial is currently recruiting participants at various centers across the Netherlands.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients who are planned for a curative treatment with or without neoadjuvant treatment and elective pancreatic resection in one of the centres of the Dutch Pancreatic Cancer Group (i.e. all centres performing major pancreatic surgery)
  • Exclusion Criteria:
  • age \< 18 years
  • acute pancreatic resections (resection scheduled within two weeks)

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Enschede, , Netherlands

Leiden, , Netherlands

Amsterdam, , Netherlands

Breda, , Netherlands

Rotterdam, , Netherlands

Den Bosch, , Netherlands

Zwolle, , Netherlands

Eindhoven, , Netherlands

Leeuwarden, , Netherlands

Nijmegen, , Netherlands

Rotterdam, , Netherlands

Groningen, , Netherlands

Amsterdam, , Netherlands

Maastricht, , Netherlands

Utrecht, , Netherlands

Patients applied

0 patients applied

Trial Officials

Marcel den Dulk, MD PhD

Principal Investigator

Maastricht University Medical Center/ University Maastricht

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported